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1. Introduction 
The subchondral bone of the distal femur is a source of pain caused by osteoarthritis (OA) or 
spontaneous osteonecrosis of the knee. To date, nociceptive phenotype of dorsal root ganglia (DRG) 
neurons innervating the subchondral bone in rat knee joints has not been evaluated. The purpose of 
this study was to clarify the distribution and nociceptive phenotype markers (calcitonin gene-related 
peptide (CGRP), tyrosine receptor kinase A (TrkA), neurofilament 200 (NF200) and isolectin B4 
(IB4)) of DRG neurons innervating the subchondral bone of the distal femur in rats. Furthermore, we 
examined the differences in nociceptive phenotype markers between the subchondral bone and the 
knee joint afferents.  
 
2. Materials and methods 
2.1 Animals 
Male Sprague-Dawley rats (3 weeks old) were used in this study. 
2.2 Retrograde labeling 
Retrograde labeling was used to identify afferents innervating the subchondral bone of the distal 
femur and the knee joint in rats. 1.5 µl FB (10mg/ml in saline) was injected into the bilateral distal 
femoral epiphyses, while10 µl DiI (5 mg/mL in N, N dimethylformamide) was injected into the 
bilateral knee joints. At fourteen days after FB and DiI injection, the bilateral lumbar DRGs (L1-L6) 
were obtained. The DRGs were placed in 4% paraformaldehyde and 30% sucrose overnight and 
frozen in -80 degrees Celsius. Fourteen-micrometer frozen sections were then cut using a cryostat. 
2.3 Immunohistochemistry 
The sections were incubated in rabbit anti CGRP antibody, goat anti TrkA antibody, and mouse 
anti-NF200 overnight. The next day, secondary detection was performed with goat anti-rabbit 
IgG-FITC for CGRP, rabbit anti-goat IgG-FITC for TrkA and Alexa 488-conjugated donkey 
anti-mouse IgG for NF200. The sections for IB4 were incubated in IB4-FITC conjugate (10 µg/ml).  
2.4 Microscopic observation 
The segmental distribution and the soma size of FB and DiI-labeled neurons were examined. For 
each FB and DiI-labeled neuron, CGRP, TrkA, NF200 expression, and IB4 binding were quantified 
as the percentage of total FB and DiI-labeled neurons. 
 
3 .  Results 
3.1 Retrograde labeling   
Of the FB-labeled neurons (subchondral bone afferents), 60% were localized in L3 DRGs. Of the 
DiI-labeled neurons (knee joint afferents), 67% were distributed in L3 and L4 DRGs. There were no 
significant differences in soma size distribution between FB and DiI labeled neurons. 
3.2 Immunohistochemistry   
The percentage of CGRP and TrkA-immunoreactive (IR) neurons in FB-labeled neurons 
(subchondral bone afferents) was significantly higher than DiI-labeled neurons (knee joint afferents), 
respectively (p < 0.05). On the other hand, the percentage of NF200-IR neurons in DiI-labeled 
neurons (knee joint afferents) was significantly higher than FB-labeled neurons (subchondral bone 
afferents) (p < 0.05). IB4 binding neurons were hardly ever present in FB and DiI-labeled neurons. 
There were no significant differences in soma size distribution of CGRP-IR and TrkA-IR neurons 
between FB and DiI-labeled neurons, whereas NF200-IR neurons among DiI-labeled neurons (knee 
joint afferents) were significantly larger than FB-labeled neurons (subchondral bone afferents) (p < 
0.05).  
 
4. Discussion 
This is the first study to evaluate nociceptive phenotype of DRG neurons innervating the 
subchondral bone of the distal femur in rats. Our results showed significant differences in 
nociceptive phenotype between the subchondral bone and the knee joint afferents. As a whole, the 
majority of DRG neurons innervating the subchondral bone and the knee joint were CGRP-IR and 
TrkA-IR. IB4 binding neurons were hardly ever present. The percentage of CGRP-IR and TrkA-IR 
neurons innervating the subchondral bone was significantly higher than the knee joint. The 
peptidergic neurons containing neuropeptides such as CGRP are considered particularly important in 
transmitting inflammatory pain. Our results suggested the subchondral bone afferents could respond 
more sensitively to inflammation than the knee joint afferents. 
In conclusion, we clarified nociceptive phenotype of DRG neurons innervating the subchondral 
bone in rat knee joints. It is expected that therapeutic approaches targeting CGRP and TrkA could 
attenuate pain from the subchondral bone in knee joints. 
 
 
